Univar Solutions and Novozymes® Partner to Bring Innovative, Sustainable Biotechnology Products to Customers in the United States and Canada
Univar Solutions (NYSE: UNVR) and Novozymes announced an expanded partnership, effective April 1, to serve the U.S. and Canadian markets for homecare, industrial cleaning, and beverages. This collaboration focuses on utilizing sustainable biological solutions, enhancing product performance, and improving customer experience through digital strategies. The agreement builds on their successful 15-year relationship in Europe, aiming to leverage innovations in enzyme and microbial technologies. Together, they strive to meet sustainability goals and capitalize on consumer demand for eco-friendly products.
- Partnership expansion into the U.S. and Canadian markets can drive growth.
- Utilization of next-generation biological solutions may improve sustainability and product performance.
- Enhanced digital strategies and customer experience initiatives are expected to benefit clients.
- None.
Under the agreement, Novozymes will continue to utilize direct sales in addition to Univar Solutions' strong distribution capability to address customers of all sizes
DOWNERS GROVE, Ill. and RALEIGH, N.C., March 15, 2021 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "the Company"), a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, today announced an agreement, effective April 1, to expand the existing partnership into the U.S. and Canadian homecare, industrial cleaning, and beverages markets. The ongoing and expanding relationship between the two companies demonstrates a shared commitment to providing customers with a portfolio of ingredients designed to help improve product performance and enable solutions that have the potential to bring more sustainable products to the homecare, industrial cleaning and beverages markets through better performing formulations.
By using next-generation biological solutions through leading enzyme and microbial innovations in place of traditional chemicals, customers in the homecare and industrial cleaning and beverage ingredient sectors can help meet sustainability goals and better capitalize on consumer demand.
"Together with Novozymes, we are collaborating at the intersection of science and technology to fulfill our purpose of keeping communities healthy, fed, clean and safe. We remain committed to delivering the high quality, sustainable ingredients and technical expertise our customers are looking for in 2021 and beyond," said Nick Powell, SVP, president, Specialty Chemicals and Ingredients for Univar Solutions. "We believe this will be an extension of our already successful partnership with Novozymes, leveraging our strategy to build global relationships that deliver consistency and growth to our customers and suppliers in multiple regions."
The exclusive distribution agreement builds upon the companies' existing partnership in Europe. Industrial enzymes and microorganisms help customers more efficiently use raw materials, reduce energy consumption and potentially replace traditional chemicals with more sustainable alternatives for a more diverse product offering. Novozymes will work closely with the Univar Solutions flagship solution center in Houston, Texas, which is home to a global center of excellence for innovation in the homecare and industrial cleaning industry.
"Univar Solutions and Novozymes have had a very productive and successful collaboration in Europe for over 15 years – and expanding the partnership into North America will allow the two companies to establish synergies with significant benefits to customers in the region," said Arnaud Melin, Novozymes' vice president of Consumer Biosolutions, Americas. "Some of the benefits include coming together to enhance our digital strategies and collaborating to better the customer experience through more online tools to help customers improve efficiency, yields, and reduce costs – accessing and benefiting more easily from our growing range of biological solutions and innovation."
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, Novozymes improves industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bio-innovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com.
NASDAQ OMX: NZYM-B • 6,500 employees • DKK 14,5 billion turnover • 30+ industries • 700+ products
About Univar Solutions
Univar Solutions (NYSE: UNVR) is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and North American sales force, unparalleled logistics know-how, deep market and regulatory knowledge, world-class formulation and recipe development, and leading digital tools the company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. Univar Solutions is committed to helping customers and suppliers innovate and grow together. Learn more at www.univarsolutions.com.
Forward-Looking Statements
This press release includes certain statements relating to future events and our intentions, beliefs, expectations, and predictions for the future, which are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the expectations and assumptions. A detailed discussion of these factors and uncertainties is contained in the Company's filings with the Securities and Exchange Commission. Potential factors that could affect such forward-looking statements include, among others: the ultimate geographic spread of the COVID-19 pandemic; the duration and severity of the COVID-19 pandemic; actions that may be taken by governmental authorities to address or otherwise mitigate the impact of the COVID-19 pandemic; the potential negative impacts of COVID-19 on the global economy and our customers and suppliers; the overall impact of the COVID-19 pandemic on our business, results of operations and financial condition; other fluctuations in general economic conditions, particularly in industrial production and the demands of our customers; significant changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including as a result of competitor consolidation; significant changes in the pricing, demand and availability of chemicals; our levels of indebtedness, the restrictions imposed by our debt instruments, and our ability to obtain additional financing when needed; the broad spectrum of laws and regulations that we are subject to, including extensive environmental, health and safety laws and regulations; an inability to integrate the business and systems of companies we acquire, including of Nexeo Solutions, Inc., or to realize the anticipated benefits of such acquisitions; potential business disruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationship with third party providers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we carry; operational risks for which we may not be adequately insured; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; potential impairment of goodwill; liabilities associated with acquisitions, ventures and strategic investments; negative developments affecting our pension plans and multi-employer pensions; labor disruptions associated with the unionized portion of our workforce; and the other factors described in the Company's filings with the Securities and Exchange Commission. We caution you that the forward-looking information presented in this press release is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek, "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/univar-solutions-and-novozymes-partner-to-bring-innovative-sustainable-biotechnology-products-to-customers-in-the-united-states-and-canada-301247010.html
SOURCE Univar Solutions Inc.
FAQ
What is the significance of the UNVR and Novozymes partnership announced on March 15, 2021?
When does the partnership between Univar Solutions and Novozymes take effect?
How will the UNVR and Novozymes collaboration benefit customers?
What markets are impacted by the Univar and Novozymes agreement?
